Healthtech firm Thyrocare (which is in 12 stock screeners) has seen fresh insider trade purchases by its promoters. Promoters bought 82,900 Thyrocare shares in mid Feb, and 10,000 shares today (26 April). The company's share price is near its year low, and technicals are weak. Share price fell after the company showed YoY negative net profit growth and EPS growth in the December quarter.